
Enko is an AI-informed crop health company focused on revolutionizing agriculture by applying pharmaceutical industry practices to crop protection. Their proprietary platform, ENKOMPASS™, utilizes DNA-encoded libraries, AI, and machine learning to discover and develop novel products that help farmers protect their crops from pests and diseases. Enko aims to set new industry standards in safety, sustainability, and environmental impact, providing effective and earth-friendly solutions for crop production.

Enko is an AI-informed crop health company focused on revolutionizing agriculture by applying pharmaceutical industry practices to crop protection. Their proprietary platform, ENKOMPASS™, utilizes DNA-encoded libraries, AI, and machine learning to discover and develop novel products that help farmers protect their crops from pests and diseases. Enko aims to set new industry standards in safety, sustainability, and environmental impact, providing effective and earth-friendly solutions for crop production.
Founded: 2017
Headquarters: Mystic, Connecticut
Focus: AI-informed crop health and pharma-style discovery for crop protection
Proprietary platform: ENKOMPASS (DNA-encoded libraries + AI/ML)
Reported total funding (company disclosures): $134,699,999 USD
Crop protection (pests, weeds, diseases) and sustainable agricultural inputs
2017
Agriculture and Farming
$45,000,000
Company announced Series B and reported total funding to date of $66M at launch.
$70,000,000
Announced $70M Series C.
$80,000,000
Company reported completion of Series C.
“Bill & Melinda Gates Foundation; Anterra Capital; Finistere Ventures; Nufarm; Novalis LifeSciences; Germin8 Ventures; TO Ventures Food; Connecticut Innovations; Rabo Food & Agri Innovation Fund; Alumni Ventures; Akroyd LLC; Castor Ventures; Endeavor8; Evan Brown; Rabobank Food & Agri Innovation Fund; Taher Gozal”